Page results
-
Diasend is being upgraded to Glooko. The children and young people's diabetes team at UCLH will be upgrading later in the year.
-
UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.
-
We are asking patients to follow some protocols before they come to UCLH and would appreciate it if you could reiterate this with your patients when you refer them.
-
Around 1 in 250 women may experience consciousness during pregnancy-related surgery under general anaesthesia, according to a national study which sheds light on why this occurs.
-
This page explains what you can expect after you have been referred to the Lymphoedema Service at University College London Hospitals (UCLH) for a video or telephone appointment.
-
The Getting Ready for Transition (GReaT) Group is an interactive workshop for young people with Type I Diabetes, who will be transitioning to secondary school in September, and their parents.
-
This page is for patients who are doing a face-to-face breath test in the hospital. Please read it carefully before you arrive for your test.
-
Getting Ready for Transition to Secondary School (GReaT) event for parents of children with type 1 diabetes
-
How to access your video appointment using MyCare UCLH with Microsoft Teams patient information page.
-
Information about making a donation to the Haematology Cancer Care charity fund at UCLH
File results
-
FOI/2023/0299 - Trust Medical Examiner contact details
-
FOI/2023/0338 - Individuals with a change to a gene called CACNA1C for 2021 and 2022
-
FOI/2023/0351 - Senior staff contact details for non-clinical workforce
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care
-
FOI/2023/0341 - Senior staff contact details
-
FOI/2023/0340 - NHS charging of overseas visitors
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0305 - Trust held non-pharmaceutical consignment stock holding
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2020/0002 - Surgical tools left inside patients